🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchOrforglipron ATTAIN-4 — looking for input Page 3

Orforglipron ATTAIN-4 — looking for input

LabKate Sat, Feb 7, 2026 at 2:59 PM 14 replies 1,111 viewsPage 3 of 3
NurseKim_ATL
Senior Member
1,678
7,234
Feb 2024
Atlanta, GA
Feb 12, 2026 at 5:03 AM#11
PharmD_Rodriguez said:
The version of this that has an answer is narrower than the version being asked.

No disagreement, though it depends on where somebody is starting from, and this thread has been assuming a starting point nobody stated.

4 2denise_HTX, raj_cambridge, ingrid_STO and 1 other
Reply Quote Save Share Report
greg_boulder
Member
345
1,567
Jul 2024
Boulder, CO
Feb 12, 2026 at 8:50 AM#12
pete_RVA said:
The manufacturing argument is the underrated one.

This is exactly what I could not find anywhere else.

5 3fiona_VT, denise_HTX, raj_cambridge and 2 others
Reply Quote Save Share Report
bbq_ray_KC
Member
378
1,678
Jul 2024
Kansas City, KS
Feb 12, 2026 at 12:37 PM#13
PharmD_Rodriguez said:
The version of this that has an answer is narrower than the version being asked.

I read this differently. The confidence in this thread is running ahead of the evidence, and I would rather the uncertainty were stated than smoothed over because it is unsatisfying.

Ask again with the specifics and you will get a better answer than this one.

6 4InsuranceTom, WendyG_ATL, SaraMom3 and 3 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
PeptideSynthNJ
Member
234
1,234
Aug 2024
Princeton, NJ
Feb 12, 2026 at 4:24 PM#14

Adding the numbers, since they settle part of this. If you are going to change something, change one thing and give it long enough to express itself. Four weeks is the usual minimum for anything pharmacological on this board, and two weeks of data has told you almost nothing.

7 5MikeKY_noInsulin, Dr.RaviCardio, jennifer_SEA and 4 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Feb 12, 2026 at 8:11 PM#15

Moderator note: good thread. Keeping it here rather than moving it, because the question is general enough to be useful.

Last edited: Feb 12, 2026 at 10:11 PM
8 6PurityPaulOR, MaxMetOK, MounjBrad and 5 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register